Interview with Vicki St Quintin, COO, PIASA. Pharmaceutical Industry Association…
South Africa has recently achieved the 1st Millennium Development Goal (MDG) – reducing the proportion of the population living on less than 1 USD a day by half – but…
Address: Thornhill Office Park, Building No 5, 94 Bekker Street
Vorna Valley 1686, South Africa ,South Africa
Tel: +27 11 805 51 00
Web: http://www.piasa.co.za/default.asp
The Pharmaceutical Industry Association of South Africa (PIASA) is a trade association of companies involved in the manufacture and/or marketing of prescription medicines in South Africa.
Membership is voluntary and includes a broad representation of foreign multinational pharmaceutical companies and local companies, both large and small. PIASA currently represents approximately 33% of the total private sector pharmaceutical market in South Africa.
The members of PIASA aim to bring the best medicines to the South African market. PIASA companies are important members of the South African business community, marketing medicines, including both innovative and generic medicines, to the health professions. In addition to promoting and safeguarding the interests of members PIASA provides a service to the public as well as the general medical and healthcare community.
Mission
To sustain a favourable environment for the continued development of the pharmaceutical industry in South Africa as it strives to increase access to quality medicines, with the ultimate aim of saving lives and improving the quality of life for all South Africans
Values
Members of PIASA subscribe to the following values:
Respect for intellectual property rights
Commitment to good corporate governance
Commitment to the Code of Marketing Practice
Adherence to best practice in manufacturing, clinical research, distribution and regulatory affairs.
Profile
Pharmaceutical trade organisation – voluntary membership.
Members comprise research based multinational, local/generic and empowerment pharmaceutical companies operating in SA.
18 members
32% Private Sector Market Share
Represents South Africa internationally as a member of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA).
association
South Africa has recently achieved the 1st Millennium Development Goal (MDG) – reducing the proportion of the population living on less than 1 USD a day by half – but…
Medicines for Africa’s Lenias Hwenda argues that the success of the much-talked-about African Medicines Agency hinges on a critical mass of African national regulators achieving WHO Level 3 maturity status.…
Writing in the February 2024 edition of the DIA Global Forum magazine, Verena Pfaffinger and Ilona Baraniak-Lang of PharmaLex examine how the drug shortages seen in the global south during…
Tremendous strides have been made in both treatment and prevention of AIDS and it is no longer among the 10 leading causes of death globally, however an estimated 39 million…
Dr Benji Pretorius, the founder of Erada Technology Alliance and a malaria survivor himself, shares his insights into why the development of a truly effective malaria vaccine will only succeed…
Writing in the July 2023 edition of DIA’s Global Forum magazine, Nevena Miletic of Roche and the IFPMA’s Africa Regulatory Network and Ian Hudson from the Bill and Melinda Gates…
The third and final piece in Lenias Hwenda of Medicines for Africa’s series looking back at the challenges and successes of HIV/AIDS treatments over the past 40 years and potential…
The second in a three-part series looking back at the challenges and successes of HIV/AIDS treatments over the past 40 years and potential medical breakthroughs to come (read part one…
In the first of a series looking back at the challenges and successes of HIV/AIDS treatments over the past 40 years and potential medical breakthroughs to come, Lenias Hwenda of…
During the COVID-19 pandemic discussions around increasing access to medicines for low and middle-income countries (LMICs) were often centred on compulsory licensing. As a result, pharma companies were up in…
As part of a special focus on drug development and clinical research in Africa in February 2023’s DIA Global Forum magazine, Lisa Ursella Collins of Innomas Clinical Research, Leslie Sam…
Roughly half of Africa’s 1.1 billion people lack regular access to even the most essential medicines and most of Sub-Saharan Africa depends on imports which make up as much as…
Speaking exclusively to PharmaBoardroom, Medicines for Africa’s Lenias Hwenda gives a comprehensive overview of the African Medicines Agency, why such a regulatory body was needed, how it differs from the…
See our Cookie Privacy Policy Here
